Live register
Drugs in short supply
1,181 products are currently reported in shortage to the FDA. Each row links to the manufacturer’s entry, so you can see what else they make and where. Most recently updated first; page 2 of 5. What changed this week / How many companies make each one.
| Drug | Manufacturer | Presentation | Availability | Updated |
|---|---|---|---|---|
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Limited Availability | 22 Sept 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Available | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) | Unavailable | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25) | Unavailable | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) | Available | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27) | Unavailable | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) | Available | 22 Sept 26 |
| Furosemide Injection | Hospira, Inc., a Pfizer Company | Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) | Available | 22 Sept 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | Available | 22 Sept 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | Available | 22 Sept 26 |
| Heparin Sodium Injection | B. Braun Medical Inc. | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) | Limited Availability | 22 Sept 26 |
| Heparin Sodium Injection | B. Braun Medical Inc. | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) | Limited Availability | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Unavailable | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Unavailable | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Limited Availability | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Limited Availability | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Available | 22 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Available | 22 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Unavailable | 22 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Unavailable | 22 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Unavailable | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) | Unavailable | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | Available | 22 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Available | 22 Sept 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Limited Availability | 22 Sept 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Limited Availability | 22 Sept 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Limited Availability | 22 Sept 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Available | 22 Sept 26 |
| Liraglutide Injection | Novo Nordisk, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Available | 22 Sept 26 |
| Lorazepam Injection | Hospira, Inc., a Pfizer Company | Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Limited Availability | 22 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Available | 22 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Available | 22 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Available | 22 Sept 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40) | Available | 22 Sept 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41) | Available | 22 Sept 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10) | Available | 22 Sept 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38) | Available | 22 Sept 26 |
| Methotrexate Sodium Injection | Hospira, Inc., a Pfizer Company | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25) | Available | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Available | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Unavailable | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Unavailable | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Limited Availability | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Available | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Unavailable | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Limited Availability | 22 Sept 26 |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Unavailable | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) | Unavailable | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Unavailable | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) | Limited Availability | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Available | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Available | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Available | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Available | 22 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) | Unavailable | 22 Sept 26 |
| Promethazine Hydrochloride Injection | XGen Pharmaceuticals DJB, Inc. | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3) | Available | 22 Sept 26 |
| Promethazine Hydrochloride Injection | XGen Pharmaceuticals DJB, Inc. | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6) | Unvailable | 22 Sept 26 |
| Rocuronium Bromide Injection | XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | Available | 22 Sept 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Available | 22 Sept 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Available | 22 Sept 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Available | 22 Sept 26 |
| Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Available | 22 Sept 26 |
| Rocuronium Bromide Injection | XGen Pharmaceuticals DJB, Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | Available | 22 Sept 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Available | 22 Sept 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Available | 22 Sept 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Available | 22 Sept 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Available | 22 Sept 26 |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Available | 22 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) | Limited Availability | 22 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) | Available | 22 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) | Limited Availability | 22 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) | Unavailable | 22 Sept 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50) | Available | 22 Sept 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03) | Available | 22 Sept 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99) | Available | 22 Sept 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20) | Available | 22 Sept 26 |
| Sterile Water Injection | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10) | Available | 22 Sept 26 |
| Sterile Water Irrigant | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00) | Available | 22 Sept 26 |
| Sterile Water Irrigant | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10) | Available | 22 Sept 26 |
| Sufentanil Citrate Injection | Hospira, Inc., a Pfizer Company | Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Available | 22 Sept 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Available | 21 Sept 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Available | 21 Sept 26 |
| Clindamycin Phosphate Injection | Pfizer Inc. | Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Unavailable | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | Available | 21 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Limited Availability | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Unavailable | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Unavailable | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Limited Availability | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Limited Availability | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Limited Availability | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Limited Availability | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Available | 21 Sept 26 |
| Methylprednisolone Acetate Injection | Pfizer Inc. | Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Available | 21 Sept 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Limited Availability | 21 Sept 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Limited Availability | 21 Sept 26 |
| Penicillin G Benzathine Injection | Pfizer Inc. | Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Unavailable | 21 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01) | Available | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01) | Available | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01) | Available | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Granules Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01) | Unavailable | 18 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01) | Available | 18 Sept 26 |
| Atropine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Available | 18 Sept 26 |
| Azacitidine Injection | Hikma Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Available | 18 Sept 26 |
| Bupivacaine Hydrochloride Injection | ONESOURCE SPECIALTY PTE LTD | Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL 5mg / 1mL (NDC 72266-263-10) | Available | 18 Sept 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) | Unavailable | 18 Sept 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) | Unavailable | 18 Sept 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) | Unavailable | 18 Sept 26 |
| Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) | Unavailable | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) | Unavailable | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) | Limited Availability | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Available | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Available | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Available | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sagent Pharmaceuticals | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) | Limited Availability | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Available | 18 Sept 26 |
| Clindamycin Phosphate Injection | Sandoz Inc. | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Available | 18 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Available | 18 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Available | 18 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Available | 18 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) | Unavailable | 18 Sept 26 |
| Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Unavailable | 18 Sept 26 |
| Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Unavailable | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Available | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Available | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Available | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Available | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Available | 18 Sept 26 |
| Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Unavailable | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Available | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Unavailable | 18 Sept 26 |
| Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Unavailable | 18 Sept 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Available | 18 Sept 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Limited Availability | 18 Sept 26 |
| Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Available | 18 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Available | 18 Sept 26 |
| Hydromorphone Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Unavailable | 18 Sept 26 |
| Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Unavailable | 18 Sept 26 |
| Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Unavailable | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Unavailable | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Unavailable | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Available | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Unavailable | 18 Sept 26 |
| Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Unavailable | 18 Sept 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Available | 18 Sept 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Available | 18 Sept 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Available | 18 Sept 26 |
| Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Available | 18 Sept 26 |
| Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Available | 18 Sept 26 |
| Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | Limited Availability | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Available | 18 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Sun Pharmaceutical Industries, Inc. | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Available | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) | Limited Availability | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Unavailable | 18 Sept 26 |
| Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) | Limited Availability | 18 Sept 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Available | 18 Sept 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Available | 18 Sept 26 |
| Meperidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Available | 18 Sept 26 |
| Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10) | Unavailable | 18 Sept 26 |
| Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01) | Unavailable | 18 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Unavailable | 18 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) | Unavailable | 18 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Unavailable | 18 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Sun Pharmaceutical Industries, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Unavailable | 18 Sept 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Unavailable | 18 Sept 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Unavailable | 18 Sept 26 |
| Methylprednisolone Acetate Injection | Sagent Pharmaceuticals | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Limited Availability | 18 Sept 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Available | 18 Sept 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Available | 18 Sept 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Available | 18 Sept 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Available | 18 Sept 26 |
| Midazolam Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Available | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Unavailable | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Available | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) | Available | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Unavailable | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Available | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Available | 18 Sept 26 |
| Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) | unavailable | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25) | Unavailable | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25) | Unavailable | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35) | Available | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25) | Unavailable | 18 Sept 26 |
For manufacturers
A shortage is a sourcing event.
Every product on this list is a molecule somebody urgently needs another source for. If you hold registered capacity for any of them, list it and we will route matching requests to you.
Provenance
Source: FDA drug shortage database via openFDA, refreshed daily. Note that the openFDA feed carries no reason-for-shortage field, so availability and therapeutic category are shown instead of a cause. Shortage status changes between refreshes; check the FDA database directly before acting on it clinically. This site is not affiliated with the FDA. Need shortage exposure joined to every NDC and manufacturer as a file? See the dataset.